tiprankstipranks
Advertisement
Advertisement

Micro-X Activates First Human Trial Site for Portable Head CT Stroke Scanner at Royal Melbourne Hospital

Story Highlights
  • Micro-X has begun activating its first human Head CT trial site at Royal Melbourne Hospital, marking a key milestone.
  • The trial supports future regulatory filings and is paired with additional sites and an in-ambulance prototype to advance pre-hospital stroke imaging.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Micro-X Activates First Human Trial Site for Portable Head CT Stroke Scanner at Royal Melbourne Hospital

Meet Samuel – Your Personal Investing Prophet

An announcement from Micro-X Ltd. ( (AU:MX1) ) is now available.

Micro-X has activated its first human pilot site for its Head CT stroke scanner at the Royal Melbourne Hospital, a leading comprehensive stroke centre and home to the Melbourne Brain Centre, marking the start of installation and commissioning ahead of world-first human imaging trials using its carbon nanotube CT technology. The in-hospital study, supported by the Australian Stroke Alliance and preceded by phantom testing and expert clinical evaluation, is intended to generate data for future regulatory applications, while additional test benches are being prepared for two further trial sites and parallel work continues on an in-ambulance Head CT prototype funded by the Australian Government’s Industry Growth Program, underscoring Micro-X’s push to transform pre-hospital stroke diagnosis by bringing high-quality brain imaging directly to patients.

The most recent analyst rating on (AU:MX1) stock is a Buy with a A$0.16 price target. To see the full list of analyst forecasts on Micro-X Ltd. stock, see the AU:MX1 Stock Forecast page.

More about Micro-X Ltd.

Micro-X Ltd is an ASX-listed hi-tech company specialising in cold cathode, carbon nanotube X-ray emitter technology for global health and security markets. Its miniaturised, low-power x-ray systems underpin mobile digital radiology products used in healthcare, military and veterinary settings, as well as next-generation security screening and advanced CT imaging projects, including a miniature brain CT imager for pre-hospital stroke diagnosis and a full-body CT system under development for US government agencies. The company operates a vertically integrated design and manufacturing facility in Adelaide and is expanding its US presence through a growing technical and commercial team in Seattle.

Average Trading Volume: 246,312

Technical Sentiment Signal: Hold

Current Market Cap: A$63.89M

For detailed information about MX1 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1